177Lu-FAP-2286
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 177Lu-FAP-2286, covering 2025-03-18 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of 177Lu-FAP-2286 in Advanced Solid Tumors [Phase 1, Phase 2]